130
Active Trials
46
Phase 1
53
Phase 2
44
Phase 3
12
Therapeutic Areas
Oncology
63 active / 113 total
Solid Tumor (Advanced)
29 active
7 Ph3
61 total since 2015
Multiple Myeloma
18 active
7 Ph3
27 total since 2015
Lung Cancer (General)
5 active
3 Ph3
7 total since 2015
Myelofibrosis
2 active
2 total since 2015
Melanoma
1 active
2 total since 2015
Sarcoma
1 active
2 total since 2015
MDS
1 active
2 total since 2015
Colorectal Cancer
1 active
1 total since 2015
Endometrial Cancer
1 active
1 total since 2015
Hodgkin Lymphoma
1 active
1 total since 2015
Brain Tumor
1 active
1 total since 2015
Glioblastoma
1 active
1 total since 2015
Hepatocellular Carcinoma
1 active
1 total since 2015
ALL
0 active
3 total since 2015
Hematologic Malignancies
0 active
1 total since 2015
Infectious Disease
19 active / 115 total
Hepatitis B
7 active
2 Ph3
28 total since 2015
RSV
5 active
3 Ph3
36 total since 2015
Influenza
4 active
20 total since 2015
Malaria
3 active
1 Ph3
13 total since 2015
COVID-19
0 active
7 total since 2015
Tuberculosis
0 active
5 total since 2015
HIV
0 active
4 total since 2015
Bacterial Infections
0 active
1 total since 2015
Fungal Infections
0 active
1 total since 2015
Immunology
16 active / 130 total
Ankylosing Spondylitis
7 active
3 Ph3
49 total since 2015
Lupus
5 active
1 Ph3
13 total since 2015
Rheumatoid Arthritis
4 active
1 Ph3
50 total since 2015
Atopic Dermatitis
0 active
8 total since 2015
Psoriasis
0 active
7 total since 2015
IBD
0 active
2 total since 2015
Crohn's Disease
0 active
1 total since 2015
Respiratory
16 active / 121 total
Metabolic
5 active / 15 total
CNS
2 active / 10 total
Cardiovascular
1 active / 30 total
Gastrointestinal
1 active / 5 total
Pain
0 active / 10 total
Urology
0 active / 4 total
Musculoskeletal
0 active / 3 total
Dermatology
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)